Danaher''s high valuation raises eyebrows, but its track record, strategic acquisitions, and long-term growth potential make the stock a solid (albeit unintuitive) buy for investors.

… a leading global science and technology company , Danaher is dedicated to advancing … who design innovative products to software engineers developing cutting-edge … garnered industry awards. Then there’s David, who transitioned from software development …

Danaher ($DHR) is an American global conglomerate with a strong presence in the life sciences and diagnostics industries. It’s an under-the-radar c…

Insider Sale: Senior Vice President - General Counsel Brian Ellis Sells 9,600 Shares of Danaher Corp (DHR)

On CNBC''s “ Halftime Report Final Trades ,” Bryn Talkington of Requisite Capital Management named Freeport-McMoRan Inc . (NYSE: FCX ) as her final trade . On July 23, Freeport-McMoRan said second-quarter revenue came in at $6.62 billion, beating the consensus of $5.99 billion. Adjusted EPS was 46 cents, beating the consensus of 38 cents. The company also announced a $7.5 billion expansion of its El Abra copper mine in northern Chile. Freshly-appointed CEO Kathleen Quirk made this announcement during an earnings call. Don''t forget … Full story available on Benzinga.com

https://www.investing.com/news/company-news/danaher-corp-reaches-52week-high-hitting-27313-93CH-3536614

https://www.investing.com/news/company-news/td-cowen-raises-danaher-stock-price-target-on-strong-performance-93CH-3534469

This quarter was exactly what we needed to see from the life sciences company.

Danaher Corporation beat analysts'' expectations on the top and bottom lines with its second-quarter results, sending shares higher in intraday trading Tuesday.

The biotechnology, diagnostics, and life sciences company looks set to return to its long-term growth rate.